FBXW7 and hepatocellular carcinoma: On the other hand, in vivo studies have suggested that the downregulation of miR-92a suppresses the biological processes of tumor growth in HCC and that F-box and WD repeat domain-containing 7 (PBXW7) is a direct target of miR-92a, promoting tumor progression in this setting (Yang et al., 2015).